Fibronectin: Functional character and role in alcoholic liver disease

World Journal of Gastroenterology

Volumn 17, Issue 20, 2011, Pages 2482-2499

  Aziz Seible, Razia S ^a   Casey, Carol A ^b,c  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

Alcoholic liverdisease; Cellular fibronectin; Endocytosis; Fibronectin; Liver disease

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; FIBRONECTIN; GLYCOPROTEIN;

ALCOHOL LIVER DISEASE; ARTICLE; CELL ACTIVITY; CELL FUNCTION; CELL TYPE; DISEASE COURSE; ENDOTHELIUM CELL; HUMAN; LIVER SINUSOID; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; STELLATE CELL; TISSUE INJURY;

EID: 79957870535     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i20.2482     Document Type: Article

References (154)

1. Morrison PR, Edsall JT, Miller SG. Preparation and properties of serum and plasma proteins; the separation of purified fibrinogen from fraction I of human plasma. J Am Chem Soc 1948; 70: 3103-3108
2. Gahmberg CG, Hakomori SI. Altered growth behavior of malignant cells associated with changes in externally labeled glycoprotein and glycolipid. Proc Natl Acad Sci USA 1973; 70: 3329-3333
3. Vaheri A, Ruoslahti E. Disappearance of a major cell-type specific surface glycoprotein antigen (SF) after transformation of fibroblasts by Rous sarcoma virus. Int J Cancer 1974; 13: 579-586
4. Hynes RO. Alteration of cell-surface proteins by viral transformation and by proteolysis. Proc Natl Acad Sci USA 1973; 70: 3170-3174
5. Yamada KM, Kennedy DW. Fibroblast cellular and plasma fibronectins are similar but not identical. J Cell Biol 1979; 80: 492-498
6. Yamada KM, Olden K. Fibronectins--adhesive glycoproteins of cell surface and blood. Nature 1978; 275: 179-184
7. Vuento M, Wrann M, Ruoslahti E. Similarity of fibronectins isolated from human plasma and spent fibroblast culture medium. FEBS Lett 1977; 82: 227-231
8. Hynes RO. Fibronectins. In: Rich A, editor. New York: Springer-Verlag, 1990: 113-175
9. Owens RJ, Kornblihtt AR, Baralle FE. Fibronectin, the generation of multiple polypeptides from a single gene. Oxf Surv Eukaryot Genes 1986; 3: 141-160
10. Schwarzbauer JE. Fibronectin: from gene to protein. Curr Opin Cell Biol 1991; 3: 786-791
11. Schwarzbauer JE, Spencer CS, Wilson CL. Selective secretion of alternatively spliced fibronectin variants. J Cell Biol 1989; 109: 3445-3453
12. Ali IU. Phosphorylation of fibronectin in quiescent and growing cell cultures. FEBS Lett 1983; 151: 45-48
13. Fukuda M, Levery SB, Hakomori S. Carbohydrate structure of hamster plasma fibronectin. Evidence for chemical diver-sity between cellular and plasma fibronectins. J Biol Chem 1982; 257: 6856-6860
14. Olden K, Parent JB, White SL. Carbohydrate moieties of glycoproteins. A re-evaluation of their function. Biochim Biophys Acta 1982; 650: 209-232
15. Jones GE, Arumugham RG, Tanzer ML. Fibronectin glycosylation modulates fibroblast adhesion and spreading. J Cell Biol 1986; 103: 1663-1670
16. Rotundo RF, Rebres RA, McKeown-Longo PJ, Blumenstock FA, Saba TM. Circulating cellular fibronectin may be a natural ligand for the hepatic asialoglycoprotein receptor: possible pathway for fibronectin deposition and turnover in the rat liver. Hepatology 1998; 28: 475-485
17. Rotundo RF, Vincent PA, McKeown-Longo PJ, Blumenstock FA, Saba TM. Hepatic fibronectin matrix turnover in rats: involvement of the asialoglycoprotein receptor. Am J Physiol 1999; 277: G1189-G1199
18. Morell AG, Gregoriadis G, Scheinberg IH, Hickman J, Ashwell G. The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem 1971; 246: 1461-1467
19. George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 1993; 119: 1079-1091
20. Sekiguchi K, Hakomori S. Functional domain structure of fibronectin. Proc Natl Acad Sci USA 1980; 77: 2661-2665
21. Wagner DD, Hynes RO. Topological arrangement of the major structural features of fibronectin. J Biol Chem 1980; 255: 4304-4312
22. Hayashi M, Schlesinger DH, Kennedy DW, Yamada KM. Isolation and characterization of a heparin-binding domain of cellular fibronectin. J Biol Chem 1980; 255: 10017-10020
23. Hörmann H, Seidl M. Affinity chromatography on immobilized fibrin monomer, III. The fibrin affinity center of fibronectin. Hoppe Seylers Z Physiol Chem 1980; 361: 1449-1452
24. Emmerling MR, Johnson CD, Mosher DF, Lipton BH, Lilien JE. Cross-linking and binding of fibronectin with asymmetric acetylcholinesterase. Biochemistry 1981; 20: 3242-3247
25. Mosher DF, Proctor RA. Binding and factor XIIIa-mediated cross-linking of a 27-kilodalton fragment of fibronectin to Staphylococcus aureus. Science 1980; 209: 927-929
26. Homandberg GA, Kramer-Bjerke J. Thrombospondin binds to amino-terminal fragments of plasma fibronectin. Thromb Res 1987; 48: 329-335
27. Yamada KM. Cell surface interactions with extracellular materials. Annu Rev Biochem 1983; 52: 761-799
28. Leikina E, Mertts MV, Kuznetsova N, Leikin S. Type I collagen is thermally unstable at body temperature. Proc Natl Acad Sci USA 2002; 99: 1314-1318
29. Rimoldi MT, Tenner AJ, Bobak DA, Joiner KA. Complement component C1q enhances invasion of human mononuclear phagocytes and fibroblasts by Trypanosoma cruzi trypomastigotes. J Clin Invest 1989; 84: 1982-1989
30. Hayashi M, Yamada KM. Domain structure of the carboxylterminal half of human plasma fibronectin. J Biol Chem 1983; 258: 3332-3340
31. Astrof S, Hynes RO. Fibronectins in vascular morphogenesis. Angiogenesis 2009; 12: 165-175
32. Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994; 127: 2037-2048
33. Kriegsmann J, Berndt A, Hansen T, Borsi L, Zardi L, Bräuer R, Petrow PK, Otto M, Kirkpatrick CJ, Gay S, Kosmehl H. Expression of fibronectin splice variants and oncofetal glycosylated fibronectin in the synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Rheumatol Int 2004; 24: 25-33
34. Muro AF, Moretti FA, Moore BB, Yan M, Atrasz RG, Wilke CA, Flaherty KR, Martinez FJ, Tsui JL, Sheppard D, Baralle FE, Toews GB, White ES. An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med 2008; 177: 638-645
35. Vartio T, Laitinen L, Närvänen O, Cutolo M, Thornell LE, Zardi L, Virtanen I. Differential expression of the ED sequence- containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci 1987; 88 (Pt 4): 419-430
36. Pagani F, Zagato L, Vergani C, Casari G, Sidoli A, Baralle FE. Tissue-specific splicing pattern of fibronectin messenger RNA precursor during development and aging in rat. J Cell Biol 1991; 113: 1223-1229
37. Caputi M, Melo CA, Baralle FE. Regulation of fibronectin expression in rat regenerating liver. Nucleic Acids Res 1995; 23: 238-243
38. Oyama F, Hirohashi S, Sakamoto M, Titani K, Sekiguchi K. Coordinate oncodevelopmental modulation of alternative splicing of fibronectin pre-messenger RNA at ED-A, ED-B, and CS1 regions in human liver tumors. Cancer Res 1993; 53: 2005-2011
39. Csiszar A, Wiebe C, Larjava H, Häkkinen L. Distinctive molecular composition of human gingival interdental papilla. J Periodontol 2007; 78: 304-314
40. Kilian O, Dahse R, Alt V, Zardi L, Rosenhahn J, Exner U, Battmann A, Schnettler R, Kosmehl H. Expression of EDA and EDB fibronectin splice variants in bone. Bone 2004; 35: 1334-1345
41. Van Vliet A, Baelde HJ, Vleming LJ, de Heer E, Bruijn JA. Distribution of fibronectin isoforms in human renal disease. J Pathol 2001; 193: 256-262
42. Oyama F, Hirohashi S, Shimosato Y, Titani K, Sekiguchi K. Oncodevelopmental regulation of the alternative splicing of fibronectin pre-messenger RNA in human lung tissues. Cancer Res 1990; 50: 1075-1078
43. Han F, Adams CS, Tao Z, Williams CJ, Zaka R, Tuan RS, Norton PA, Hickok NJ. Transforming growth factor-beta1 (TGF-beta1) regulates ATDC5 chondrogenic differentiation and fibronectin isoform expression. J Cell Biochem 2005; 95: 750-762
44. Fukuda T, Yoshida N, Kataoka Y, Manabe R, Mizuno-Horikawa Y, Sato M, Kuriyama K, Yasui N, Sekiguchi K. Mice lacking the EDB segment of fibronectin develop normally but exhibit reduced cell growth and fibronectin matrix assembly in vitro. Cancer Res 2002; 62: 5603-5610
45. Chen W, Culp LA. Adhesion mediated by fibronectin's alternatively spliced EDb (EIIIB) and its neighboring type III repeats. Exp Cell Res 1996; 223: 9-19
46. Muro AF, Chauhan AK, Gajovic S, Iaconcig A, Porro F, Stanta G, Baralle FE. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J Cell Biol 2003; 162: 149-160
47. Tan MH, Sun Z, Opitz SL, Schmidt TE, Peters JH, George EL. Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood 2004; 104: 11-18
48. Chauhan AK, Moretti FA, Iaconcig A, Baralle FE, Muro AF. Impaired motor coordination in mice lacking the EDA exon of the fibronectin gene. Behav Brain Res 2005; 161: 31-38
49. Matuskova J, Chauhan AK, Cambien B, Astrof S, Dole VS, Piffath CL, Hynes RO, Wagner DD. Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles. Arterioscler Thromb Vasc Biol 2006; 26: 1391-1396
50. Main AL, Harvey TS, Baron M, Boyd J, Campbell ID. The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions. Cell 1992; 71: 671-678
51. Aota S, Nagai T, Yamada KM. Characterization of regions of fibronectin besides the arginine-glycine-aspartic acid sequence required for adhesive function of the cell-binding domain using site-directed mutagenesis. J Biol Chem 1991; 266: 15938-15943
52. Bencharit S, Cui CB, Siddiqui A, Howard-Williams EL, Sondek J, Zuobi-Hasona K, Aukhil I. Structural insights into fibronectin type III domain-mediated signaling. J Mol Biol 2007; 367: 303-309
53. Carnemolla B, Leprini A, Allemanni G, Saginati M, Zardi L. The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence. J Biol Chem 1992; 267: 24689-24692
54. Hynes RO. Integrins: a family of cell surface receptors. Cell 1987; 48: 549-554
55. Tamkun JW, DeSimone DW, Fonda D, Patel RS, Buck C, Horwitz AF, Hynes RO. Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin. Cell 1986; 46: 271-282
56. Takagi J, Strokovich K, Springer TA, Walz T. Structure of integrin alpha5beta1 in complex with fibronectin. EMBO J 2003; 22: 4607-4615
57. Arnaout MA, Mahalingam B, Xiong JP. Integrin structure, allostery, and bidirectional signaling. Annu Rev Cell Dev Biol 2005; 21: 381-410
58. Dedhar S, Hannigan GE. Integrin cytoplasmic interactions and bidirectional transmembrane signalling. Curr Opin Cell Biol 1996; 8: 657-669
59. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. Ligand binding to integrins. J Biol Chem 2000; 275: 21785-21788
60. Bowditch RD, Hariharan M, Tominna EF, Smith JW, Yamada KM, Getzoff ED, Ginsberg MH. Identification of a novel integrin binding site in fibronectin. Differential utilization by beta 3 integrins. J Biol Chem 1994; 269: 10856-10863
61. Curnis F, Longhi R, Crippa L, Cattaneo A, Dondossola E, Bachi A, Corti A. Spontaneous formation of L-isoaspartate and gain of function in fibronectin. J Biol Chem 2006; 281: 36466-36476
62. Shimizu T, Matsuoka Y, Shirasawa T. Biological significance of isoaspartate and its repair system. Biol Pharm Bull 2005; 28: 1590-1596
63. Shimizu T, Fukuda H, Murayama S, Izumiyama N, Shirasawa T. Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease. J Neurosci Res 2002; 70: 451-461
64. Lanthier J, Bouthillier A, Lapointe M, Demeule M, Béliveau R, Desrosiers RR. Down-regulation of protein L-isoaspartyl methyltransferase in human epileptic hippocampus contributes to generation of damaged tubulin. J Neurochem 2002; 83: 581-591
65. Santas AJ, Peterson JA, Halbleib JL, Craig SE, Humphries MJ, Peters DM. Alternative splicing of the IIICS domain in fibronectin governs the role of the heparin II domain in fibrillogenesis and cell spreading. J Biol Chem 2002; 277: 13650-13658
66. Humphries MJ, Komoriya A, Akiyama SK, Olden K, Yamada KM. Identification of two distinct regions of the type III connecting segment of human plasma fibronectin that promote cell type-specific adhesion. J Biol Chem 1987; 262: 6886-6892
67. Komoriya A, Green LJ, Mervic M, Yamada SS, Yamada KM, Humphries MJ. The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. J Biol Chem 1991; 266: 15075-15079
68. Mould AP, Humphries MJ. Identification of a novel recognition sequence for the integrin alpha 4 beta 1 in the COOHterminal heparin-binding domain of fibronectin. EMBO J 1991; 10: 4089-4095
69. Shinde AV, Bystroff C, Wang C, Vogelezang MG, Vincent PA, Hynes RO, Van De Water L. Identification of the peptide sequences within the EIIIA (EDA) segment of fibronectin that mediate integrin alpha9beta1-dependent cellular activities. J Biol Chem 2008; 283: 2858-2870
70. Tumova S, Woods A, Couchman JR. Heparan sulfate chains from glypican and syndecans bind the Hep II domain of fibronectin similarly despite minor structural differences. J Biol Chem 2000; 275: 9410-9417
71. Midwood KS, Mao Y, Hsia HC, Valenick LV, Schwarzbauer JE. Modulation of cell-fibronectin matrix interactions during tissue repair. J Investig Dermatol Symp Proc 2006; 11: 73-78
72. Kusano Y, Oguri K, Nagayasu Y, Munesue S, Ishihara M, Saiki I, Yonekura H, Yamamoto H, Okayama M. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin. Exp Cell Res 2000; 256: 434-444
73. Echtermeyer F, Streit M, Wilcox-Adelman S, Saoncella S, Denhez F, Detmar M, Goetinck P. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest 2001; 107: R9-R14
74. Integrins and syndecan-4 make distinct, but critical, contributions to adhesion contact formation. Soft Matter 2007; 3: 372-376
75. Humphries MJ, Mostafavi-Pour Z, Morgan MR, Deakin NO, Messent AJ, Bass MD. Integrin-syndecan cooperation governs the assembly of signalling complexes during cell spreading. Novartis Found Symp 2005; 269: 178-188; discussion 188-192, 223-230
76. Morgan MR, Byron A, Humphries MJ, Bass MD. Giving off mixed signals--distinct functions of alpha5beta1 and alphavbeta3 integrins in regulating cell behaviour. IUBMB Life 2009; 61: 731-738
77. Lishko VK, Yakubenko VP, Ugarova TP. The interplay between integrins alphaMbeta2 and alpha5beta1 during cell migration to fibronectin. Exp Cell Res 2003; 283: 116-126
78. Johnson KJ, Sage H, Briscoe G, Erickson HP. The compact conformation of fibronectin is determined by intramolecular ionic interactions. J Biol Chem 1999; 274: 15473-15479
79. Ugarova TP, Zamarron C, Veklich Y, Bowditch RD, Ginsberg MH, Weisel JW, Plow EF. Conformational transitions in the cell binding domain of fibronectin. Biochemistry 1995; 34: 4457-4466
80. Wierzbicka-Patynowski I, Schwarzbauer JE. The ins and outs of fibronectin matrix assembly. J Cell Sci 2003; 116: 3269-3276
81. Lemmon CA, Chen CS, Romer LH. Cell traction forces direct fibronectin matrix assembly. Biophys J 2009; 96: 729-738
82. Baneyx G, Baugh L, Vogel V. Fibronectin extension and unfolding within cell matrix fibrils controlled by cytoskeletal tension. Proc Natl Acad Sci USA 2002; 99: 5139-5143
83. Aguirre KM, McCormick RJ, Schwarzbauer JE. Fibronectin self-association is mediated by complementary sites within the amino-terminal one-third of the molecule. J Biol Chem 1994; 269: 27863-27868
84. Vakonakis I, Staunton D, Rooney LM, Campbell ID. Interdomain association in fibronectin: insight into cryptic sites and fibrillogenesis. EMBO J 2007; 26: 2575-2583
85. Das S, Banerji A, Frei E, Chatterjee A. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. Life Sci 2008; 82: 467-476
86. Saad S, Gottlieb DJ, Bradstock KF, Overall CM, Bendall LJ. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Res 2002; 62: 283-289
87. Zack MD, Arner EC, Anglin CP, Alston JT, Malfait AM, Tortorella MD. Identification of fibronectin neoepitopes present in human osteoarthritic cartilage. Arthritis Rheum 2006; 54: 2912-2922
88. Liz MA, Sousa MM. Deciphering cryptic proteases. Cell Mol Life Sci 2005; 62: 989-1002
89. Ding L, Guo D, Homandberg GA. Fibronectin fragments mediate matrix metalloproteinase upregulation and cartilage damage through proline rich tyrosine kinase 2, c-src, NF-kappaB and protein kinase Cdelta. Osteoarthritis Cartilage 2009; 17: 1385-1392
90. Jee SW, Wang S, Kapila YL. Specific pro-apoptotic fibronectin fragments modulate proteinase expression in periodontal ligament cells. J Periodontol 2004; 75: 523-530
91. Pichika R, Homandberg GA. Fibronectin fragments elevate nitric oxide (NO) and inducible NO synthetase (iNOS) levels in bovine cartilage and iNOS inhibitors block fibronectin fragment mediated damage and promote repair. Inflamm Res 2004; 53: 405-412
92. Gondokaryono SP, Ushio H, Niyonsaba F, Hara M, Takenaka H, Jayawardana ST, Ikeda S, Okumura K, Ogawa H. The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J Leukoc Biol 2007; 82: 657-665
93. Alon R, Cahalon L, Hershkoviz R, Elbaz D, Reizis B, Wallach D, Akiyama SK, Yamada KM, Lider O. TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4 T lymphocytes to the glycoprotein. J Immunol 1994; 152: 1304-1313
94. Wijelath ES, Rahman S, Namekata M, Murray J, Nishimura T, Mostafavi-Pour Z, Patel Y, Suda Y, Humphries MJ, Sobel M. Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ Res 2006; 99: 853-860
95. Vaday GG, Hershkoviz R, Rahat MA, Lahat N, Cahalon L, Lider O. Fibronectin-bound TNF-alpha stimulates monocyte matrix metalloproteinase-9 expression and regulates chemotaxis. J Leukoc Biol 2000; 68: 737-747
96. Taipale J, Miyazono K, Heldin CH, Keski-Oja J. Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol 1994; 124: 171-181
97. Rifkin DB. Latent transforming growth factor-beta (TGFbeta) binding proteins: orchestrators of TGF-beta availability. J Biol Chem 2005; 280: 7409-7412
98. Schwartz MA. Cell biology. The force is with us. Science 2009; 323: 588-589
99. Li S, Guan JL, Chien S. Biochemistry and biomechanics of cell motility. Annu Rev Biomed Eng 2005; 7: 105-150
100. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004; 16: 558-564
101. Reiske HR, Kao SC, Cary LA, Guan JL, Lai JF, Chen HC. Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration. J Biol Chem 1999; 274: 12361-12366
102. Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science 1995; 268: 233-239
103. Dovas A, Yoneda A, Couchman JR. PKCbeta-dependent activation of RhoA by syndecan-4 during focal adhesion formation. J Cell Sci 2006; 119: 2837-2846
104. Rodríguez-Juan C, de la Torre P, García-Ruiz I, Díaz-Sanjuán T, Muñoz-Yagüe T, Gómez-Izquierdo E, Solís-Muñoz P, Solís-Herruzo JA. Fibronectin increases survival of rat hepatic stellate cells--a novel profibrogenic mechanism of fibronectin. Cell Physiol Biochem 2009; 24: 271-282
105. Pulai JI, Chen H, Im HJ, Kumar S, Hanning C, Hegde PS, Loeser RF. NF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J Immunol 2005; 174: 5781-5788
106. Moretti FA, Chauhan AK, Iaconcig A, Porro F, Baralle FE, Muro AF. A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived. J Biol Chem 2007; 282: 28057-28062
107. Briggs SL. The role of fibronectin in fibroblast migration during tissue repair. J Wound Care 2005; 14: 284-287
108. Schultz GS, Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 2009; 17: 153-162
109. Jiao J, Friedman SL, Aloman C. Hepatic fibrosis. Curr Opin Gastroenterol 2009; 25: 223-229
110. Friedman SL. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 2004; 1: 98-105
111. Reynolds BC, Paton JY, Howatson AG, Ramage IJ. Reversible chronic pulmonary fibrosis associated with MMF in a pediatric patient: a case report. Pediatr Transplant 2008; 12: 228-231
112. Hahn E, Wick G, Pencev D, Timpl R. Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin. Gut 1980; 21: 63-71
113. Odenthal M, Neubauer K, Meyer zum Büschenfelde KH, Ramadori G. Localization and mRNA steady-state level of cellular fibronectin in rat liver undergoing a CCl4-induced acute damage or fibrosis. Biochim Biophys Acta 1993; 1181: 266-272
114. Haglund C, Ylätupa S, Mertaniemi P, Partanen P. Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEA. Br J Cancer 1997; 76: 777-783
115. Martinez-Hernandez A. The hepatic extracellular matrix. I. Electron immunohistochemical studies in normal rat liver. Lab Invest 1984; 51: 57-74
116. Tavian D, De Petro G, Colombi M, Portolani N, Giulini SM, Gardella R, Barlati S. RT-PCR detection of fibronectin EDA and EDB mRNA isoforms: molecular markers for hepatocellular carcinoma. Int J Cancer 1994; 56: 820-825
117. Joy D, Scott BB. To perform or not to perform liver biopsy: an alternative view. Gut 2003; 52: 610
118. Sheehan M, Haythorn P. Predictive values of various liver function tests with respect to the diagnosis of liver disease. Clin Biochem 1979; 12: 262-263
119. Scanzello CR, Plaas A, Crow MK. Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound? Curr Opin Rheumatol 2008; 20: 565-572
120. Yasuda T. Cartilage destruction by matrix degradation products. Mod Rheumatol 2006; 16: 197-205
121. Norton PA, Reis HM, Prince S, Larkin J, Pan J, Liu J, Gong Q, Zhu M, Feitelson MA. Activation of fibronectin gene expression by hepatitis B virus x antigen. J Viral Hepat 2004; 11: 332-341
122. Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 1998; 142: 873-881
123. Zhou X, Zhang Y, Zhang J, Zhu H, Zhou X, Du W, Zhang X, Chen Q. Expression of fibronectin receptor, integrin alpha 5 beta 1 of hepatic stellate cells in rat liver fibrosis. Chin Med J (Engl) 2000; 113: 272-276
124. Duryee MJ, Willis MS, Freeman TL, Kuszynski CA, Tuma DJ, Klassen LW, Thiele GM. Mechanisms of alcohol liver damage: aldehydes, scavenger receptors, and autoimmunity. Front Biosci 2004; 9: 3145-3155
125. Goldin R. The pathogenesis of alcoholic liver disease. Int J Exp Pathol 1994; 75: 71-78
126. Lieber CS. Metabolism of alcohol. Clin Liver Dis 2005; 9: 1-35
127. Schaffert CS, Duryee MJ, Hunter CD, Hamilton BC, De-Veney AL, Huerter MM, Klassen LW, Thiele GM. Alcohol metabolites and lipopolysaccharide: roles in the development and/or progression of alcoholic liver disease. World J Gastroenterol 2009; 15: 1209-1218
128. Tuma DJ, Casey CA. Dangerous byproducts of alcohol breakdown--focus on adducts. Alcohol Res Health 2003; 27: 285-290
129. You M, Crabb DW. Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. Am J Physiol Gastrointest Liver Physiol 2004; 287: G1-G6
130. Zakhari S. Overview: how is alcohol metabolized by the body? Alcohol Res Health 2006; 29: 245-254
131. Cederbaum AI. Role of lipid peroxidation and oxidative stress in alcohol toxicity. Free Radic Biol Med 1989; 7: 537-539
132. Thiele GM, Duryee MJ, Freeman TL, Sorrell MF, Willis MS, Tuma DJ, Klassen LW. Rat sinusoidal liver endothelial cells (SECs) produce pro-fibrotic factors in response to adducts formed from the metabolites of ethanol. Biochem Pharmacol 2005; 70: 1593-1600
133. Tworek BL, Wiegert RL, Jeanette JP, Tuma DJ, Casey CA. Differential effects of monensin on asialoglycoprotein receptor function after short-term ethanol administration. Biochem Pharmacol 1998; 55: 1603-1609
134. Tworek BL, Tuma DJ, Casey CA. Decreased binding of asialoglycoproteins to hepatocytes from ethanol-fed rats. Consequence of both impaired synthesis and inactivation of the asialoglycoprotein receptor. J Biol Chem 1996; 271: 2531-2538
135. McCashland TM, Tuma DJ, Sorrell MF, Casey CA. Zonal differences in ethanol-induced impairments in hepatic receptor binding. Alcohol 1993; 10: 549-554
136. McVicker BL, Casey CA. Effects of ethanol on receptormediated endocytosis in the liver. Alcohol 1999; 19: 255-260
137. McVicker BL, Tuma DJ, Kubik JA, Hindemith AM, Baldwin CR, Casey CA. The effect of ethanol on asialoglycoprotein receptor-mediated phagocytosis of apoptotic cells by rat hepatocytes. Hepatology 2002; 36: 1478-1487
138. Aziz-Seible RS, McVicker BL, Kharbanda KK, Casey CA. Cellular fibronectin stimulates hepatocytes to produce factors that promote alcohol-induced liver injury. World J Hepatol 2011; 3: 45-55
139. Gillis SE, Nagy LE. Deposition of cellular fibronectin increases before stellate cell activation in rat liver during ethanol feeding. Alcohol Clin Exp Res 1997; 21: 857-861
140. de la M Hall P, Lieber CS, DeCarli LM, French SW, Lindros KO, Järveläinen H, Bode C, Parlesak A, Bode JC. Models of alcoholic liver disease in rodents: a critical evaluation. Alcohol Clin Exp Res 2001; 25: 254S-261S
141. Sottile J, Shi F, Rublyevska I, Chiang HY, Lust J, Chandler J. Fibronectin-dependent collagen I deposition modulates the cell response to fibronectin. Am J Physiol Cell Physiol 2007; 293: C1934-C1946
142. Aziz-Seible RS, Lee SM, Kharbanda KK, McVicker BL, Casey CA. Ethanol feeding potentiates the pro-inflammatory response of kupffer cells to cellular fibronectin. Alcohol Clin Exp Res 2011; 35: 717-725
143. Tsukamoto H. Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol Clin Exp Res 1999; 23: 911-916
144. Naito M, Hasegawa G, Ebe Y, Yamamoto T. Differentiation and function of Kupffer cells. Med Electron Microsc 2004; 37: 16-28
145. Martin J, Eynstone L, Davies M, Steadman R. Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix. J Am Soc Nephrol 2001; 12: 88-96
146. Rath PC, Aggarwal BB. TNF-induced signaling in apoptosis. J Clin Immunol 1999; 19: 350-364
147. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104: 487-501
148. Kapila YL, Wang S, Dazin P, Tafolla E, Mass MJ. The heparin- binding domain and V region of fibronectin regulate apoptosis by suppression of p53 and c-myc in human primary cells. J Biol Chem 2002; 277: 8482-8491
149. Marastoni S, Ligresti G, Lorenzon E, Colombatti A, Mongiat M. Extracellular matrix: a matter of life and death. Connect Tissue Res 2008; 49: 203-206
150. Kapila YL, Kapila S, Johnson PW. Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells. Matrix Biol 1996; 15: 251-261
151. Wells RG. Cellular sources of extracellular matrix in hepatic fibrosis. Clin Liver Dis 2008; 12: 759-768, viii
152. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H, Kalluri R. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007; 282: 23337-23347
153. Klassen LW, Thiele GM, Duryee MJ, Schaffert CS, DeVeney AL, Hunter CD, Olinga P, Tuma DJ. An in vitro method of alcoholic liver injury using precision-cut liver slices from rats. Biochem Pharmacol 2008; 76: 426-436
154. Meng Q. Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 2010; 6: 733-746